The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.
about
Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers.Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in The United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).Mechanism-informed Repurposing of Minocycline Overcomes Resistance to Topoisomerase Inhibition for Peritoneal Carcinomatosis.Cost of Care for the Initial Management of Ovarian Cancer.Association Between the Subtypes of Stroke and the Various Risk Factors of Cerebrovascular Accidents: A Cross-Sectional Study
P2860
The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.
@en
type
label
The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.
@en
prefLabel
The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.
@en
P2093
P356
P1476
The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer.
@en
P2093
Melissa M Hardesty
Rafael Alfonso-Cristancho
Renata R Urban
P304
P356
10.6004/JNCCN.2016.0049
P577
2016-04-01T00:00:00Z